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ABSTRACT 
Objective: Adapalene is a medicinal ingredient that can be used to treat acne. Adapalene has a Log P value of 8.6 and has high lipophilic and low 
solubility in water and is potentially degraded. Adapalene NLC can increase biphasic drug penetration at low doses but has good reactivity and 
provides occlusive properties that can increase skin hydration, thereby accelerating acne treatment. 
Methods: Forming Adapalene NLC using the method of heat homogenization followed by ultrasonication probe. The NLC formulas used were 
Precirol ATO5 ®4.0%, Myritol ® 2%, Cremophor RH 40 1%, Plantacare 1%, Tegocare 1%, and Adapalene 0.3%. Following that is the characterization 
of particle size, polydispersity index, zeta potential, efficiency entrapment. 
Results: The results showed the measurement of particle size with a range (150-318 nm), index polydispersion showed (0.12-0.36) and zeta 
potential (-26)-(-60 mV) and efficient entrapment testing showed results (84-98 %). In the TEM morphological evaluation of images showing 
spherical and evenly distributed forms, this is in line with the results of the adapalene NLC characterization. 
Conclusion: These results suggest that NLC containing adapalene showed excellent result. 
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INTRODUCTION 
Nanostructured lipid carrier (NLC) is one of the drug delivery 
systems with modifications that is able to improve the 
physicochemical properties of an active ingredient [1]. Carrier lipid 
nanostructured is a second-generation nanocarrier as the first 
generation improvement, namely solid lipid carrier (SLN) [2]. SLN 
only consists of solid lipids without liquid lipids; this is a weakness 
of SLN because the matrix structure owned by SLN is very solid, 
resulting in low loading capacity and the possibility of the expulsion 
of the drug during storage and this system also has a high potential 
for explosive eruptions drug [3]. The liquid lipid component in NLC 
functions to overcome SLN weaknesses, namely to disrupt the 
conformation of the solid lipid matrix so that it does not become a 
perfect matrix of solid lipid crystals during storage and also the 
absorption of active substances increases [4, 5]. Adapalene (ADA) is 
a new synthetic retinoid (3rd generation) as an anti-inflammatory, 
has a high affinity for the retinoic acid (RAR) β and RAR γ receptors, 
and is effective in the treatment of mild to moderate acne in 
humans [6]. In USA, Adapalene in gel form is used for the topical 
treatment of moderate to severe acne vulgaris with a concentration 
of 0.1% and 0.3%, but the effectiveness of which is superior to that 
gel ADA 0.3% [7]. Adapalene has low solubility in water or is 
lipophilic and has a high melting point of more than 300 °C [8]. High 
ADA melting points can be associated with side effects that can make 
redness on the skin when in direct contact with the epidermal layer. 
Nanostructured carious lipids can be used to protect pharmaceutical 
active ingredients, namely adapalene which has lipophilic 
physicochemical properties and crystalline form that can irritate 
when in direct contact with the skin but have great benefits, 
especially as anti-acne [9]. NLC can increase targeted drug delivery, 
especially by topical administration route; the purpose of acne 
treatment is the dermis layer, so the NLC system is appropriate [10]. 
MATERIALS AND METHODS 
Study materials 
The ingredients used consist of active ingredients namely Adapalen 
(PT. Olon spa), Glyceryl Palmitostarate (Precirol® ATO5) solid 
lipids from PT. Gattefose, liquid lipid Caprylic Triglyceride (Myritol® 
318), surfactant PEG-40-Hydrogenated Castor Oil (Cremophore RH 
40®), surfactant Lauryl Triglyceride (Plantacare®), and Poliglyceryl-3 
Methil Distearate Glucose (Tegocare®) from Evonic Industries AG, 
Methanol Pro Analysis (Merck). 
FTIR testing 
FT-IR test is intended to determine the compatibility between the 
materials used [11, 12]. This test is carried out by analyzing the active 
substance Adapalen, Precirol® ATO5 solid lipid, and a mixture of 
Precirol® ATO5-Adapalen solid lipid. The sample is crushed and 
placed in the sample container until it meets the crystal part of 
the Agilent Cary 630 FT-IR spectrophotometer instrument then the 
sample spectrum results are compared [13]. 
X-Ray diffractometry (X-RD) testing 
Analysis of the active substance Adapalene, Precirol® ATO5 solid 
lipids, and a mixture of Tretinoin-solid lipids using the X-RD Bruker 
D8 instrument to determine the crystallinity of the ingredients used 
[14, 15]. Samples were analyzed with a scanning speed of 1°/min. 
Differential scanning calorimetry test (DSC) 
The DSC test was carried out to determine the melting point and 
properties of the material, adapalene, Precirol® ATO5 solid lipid, 
and a solid-Adapalene lipid mixture placed in an aluminum plate on 
the DSC instrument Thermal Analysis License (USA), then heated 
from 20-400 °C at speed heating 10 °C/min. The data obtained in the 
form of thermograms with thermal parameters such as onset, offset, 
and maximum peak. 
Preparation of NLCS 
NLC was made using the hot homogenization method followed by 
probe sonication [16]. As much as 0.1% of adapalene is put into 
Precirol® ATO5 and liquid lipids (Caprylic Triglyceride (Myritol® 
318) then melted (Phase A). Campervan surfactant with a water 
phase using magnetic-stirrer (IKA® C-Mag H54) (Phase B). Phase B 
is added to phase A, then stirred using a high-shear homogenizer 
(Ultra Thurrax IKA® T25) to form pre-emulsions [17-19]. The next 
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step is to reduce particle size using a sonicator probe (Ivymen 
Ultrasonic Homogenizers CY-500) [20]. 
Physicochemical characterization of particles 
Adapalene NLC formulations were characterized, consisting of 
particle size, index polydispersion, and zeta potential using Malvern 
ZSP (England) zeta sizer particle size gauges at room temperature 
(25 °C) [21]. Adapter NLC samples were taken 5 drops and then 
added with water up to 10 ml and put into a disposable cuvette[22]. 
To confirmed the formation of NLC adapalene, do to characterization 
Test X-Ray diffractometry (X-RD Bruker D8) and Differential 
Scanning Calorimetry testing is perform to recognize changes that 
occur in NLC formulated with adapalene after probe sonication 
methods [23]. 
The morphological formula of NLC adapalene was formed 
using transmission electron microscopy (TEM Jeol Japan JEM 1400. 
A total of 1 g of the adapalene NLC oil phase is dispersed in 5 ml of 
deionized water before analysis. The mixture is then stirred and 
dropped 10 µl on the specimen. A lat grid of 400 mesh then dropped 
10 ml of uranyl acetate over the grid and the rest of the droplets is 
cleaned again using filter paper, allowed to stand for 30 min to dry, 
and put into a TEM tool to capture [24]. 
Entrapment efficiency (EE) 
The adsorption efficiency calculation is performed by 1 ml 
Adapalene NLC inserted in Vivaspin filter tubes (Vivaspin, 
Goettingen, Germany) with a membrane filter that has a 5 kDa 
molecular weight cut-off and centrifuged at 14,500 rpm for 3 h. Then 
the supernatant is taken and diluted, then measured by the UV 
Spectrophotometry method (Shimadzu 1800) at the maximum 
wavelength to obtain levels of Adapalene that is not absorbed 
(unentrapped). Then the entrapment efficiency (EE) can be 
calculated using the following equation [25]: 
% EE = Total adapalene −free adapalene
Total adapalene
x 100 
RESULTS AND DISCUSSION 
Evaluation and characterization of adapalene NLC 
FT-IR test is a means of qualitative identification by involving the 
infrared ray spectrum, which provides information on the presence 
or absence of interactions on the mixture of materials used in the 
NLC formula [28]. This test consisted of a single adapalene analysis, 
a single Precirol® ATO5 solid lipid and a mixture of both. The fig. 
above shows that a single Adapalene has sharp peaks at frequencies 
of 2914.73 cm-1 and 2849.74 cm-1, while Precirol® ATO5 sharp 
peaks are at frequencies 2912.54 cm-1 and 2848.30 cm-1. This 
proves that both have similar characteristics in terms of the type of 
bond even though they have different frequencies; this difference is 
caused by the difference in vibration between the two. Similar to the 
Precirol® ATO5 spectrum, the mixture spectrum of Adapalene and 
Precirol® ATO5 has sharp peaks at 2912.54 cm-1 and 2848.30 cm-1 
without the formation of new peaks, this revealed that Adapalene 
was not detected as a whole because it had absorbed in Precirol® 
ATO5. This becomes a reference that the two sample materials 
tested are mutually compatible and besides, the absence of new 
peaks in the FT-IR spectrum pattern also provides information that 
there is no interaction between Adapalene and Precirol® ATO5 so 
that it does not form new molecular groups (fig. 1). 
 
 
Fig. 1: FTIR absorption spectra of adaplene, precirol, mixture adapalene and precirol 
 
Test X-Ray diffractometry (X-RD) is carried out so that the 
diffraction data obtained as a result of the collision between the 
sample material with electromagnetic rays such as X-rays [27]. This 
test consists of a single adapalene analysis, a single Precirol® ATO5 
solid lipid, a mixture of both, and an Apalene NLC using the X-RD 
Bruker D8 instrument to find out the crystallinity of the material 
used. Samples were analyzed with a scanning speed of 1°/min. 
XRD test results show that a single Adapalene (plot A) it can be seen 
that Adapalene has 8 crystalline peaks with 1 high-intensity peak. 
The more peaks that are formed, the more lattices that can refract X 
rays. When more rays are transmitted than rays are refracted, the 
peaks formed will slope so that they have low crystalline properties, 
conversely the narrower the width of the peaks, the higher the 
crystalline properties a sample material because the higher the 
intensity of the light that is refracted. 
Based on the diffractogram, it shows that single and has sharp peaks 
that resemble the phenomenon of grass, whereas a single Precirol® 
ATO5 (plot B) has blunt peaks with low intensity, this shows that the 
precirol® ATO5 dense lipids have the level of crystallinity is lower 
than that of Adapalene so that when Adapalene is encapsulated by 
Precirol® ATO5 the Plot D displays peaks which indicate that the 
mixture is amorphous (fig. 2). 
 
 
Fig. 2: X-Ray Difraction pattern of adapalene, precirol, mixture adapalene and precirol 
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DSC testing is performed to determine the melting point and properties 
of materials used with endothermic and exothermic phenomena[28]. A 
total of 10 mg samples (solid lipids Precirol ATO5 ®, Adapalene, 
a mixture of solid lipids and Adapalene) were placed in aluminum plates 
on the DSC instrument. The sample is heated from 20-400 °C with a 
heating speed of 10 °C/minute. Adapalene has crystalline properties, 
with a high melting point at 326 °C which indicates the amount of heat 
energy needed to be able to influence the system inside[29]. Precirol® 
ATO5 formed a curve in the range of 20.5 °-83.3 °C with an endothermic 
peak at a temperature of 59.6 °C, the mixture between Adapalen and 
Precirol® ATO5 experienced a narrowing, ie in the range of 19.4 °-
77.7 °C and had a peek at 62.4 °C. This indicates a shift in the melting 
point that occurs in the mixed sample material after Precirol® 
ATO5 and Adapalene. Mixture thermogram and Adapalene NLC did 
not form a new peak which states that Adapalene can be completely 
absorbed on its solid lipid matrix, Precirol® ATO5, which is indicated 




Fig. 3: DSC thermograms of adapalene, precirol, mixture adapalene and precirol 
 
The development of Adapalene NLC formula using Precirol Ato solid 
lipid with liquid Myritol lipid and using three types of surfactants, 
namely Plantacare, Ceremophore RH 40 and Tegocare was 
successfully produced. The parameters used to characterize the 
adapalene NLC were particle size, index polydispersion, zeta potential, 
and efficient entrapment. The results showed the measurement of 
particle size with a range (150-318 nm), index polydispersion showed 
the homogeneity of the particle size distribution. The data shows 
(0.12-0.36) a number below 0.5, this indicates that NLC formula has a 
good particle size distribution The zeta potential evaluation provides 
an overview of the repulsive force between particles that has the 
potential for particle aggregation, the zeta potential value is close to 
zero indicating aggregation, causing instability. The data shows that 
the potential zeta value is more than and result zeta potential showed 
(-26)-(-60 mV) so the NLC formula has good stability and efficient 
entrapment testing showed results (84-98 %) (table 1). 
 
Table 1: Formulation and characterization of adapalene loaded NLC 

















1 0.1% 2 2 1 - - 177.46±7.05 0.12±0.00 -60.4±0.21 95.24±0.07 
2 0.1% 3 1.75 1 - - 175.33±0.82 0.11±0.00 -40.7±12.37 88.80±0.59 
3 0.1% 4 1.5 1 - - 218.4±4.57 0.255±0.00 -50.93±10.15 93.20±1.04 
4 0.1% 5 1.25 1 - - 277.6±13.32 0.31±0.00 -26.9±1.88 94.70±0.00 
5 0.1% 6 1 1 - - 299.8±2.24 0.26±0.00 -33.53±27.26  98.46±0.00 
6 0.1% 2 2 - 1 - 156.03±6.10 0.26±0.00 -51.76±4.12 92.72±0.21 
7 0.1% 3 1.75 - 1 - 173.16±1.80 0.28±0.00 -49.3±9.89 84.93±0.00 
8 0.1% 4 1.5 - 1 - 160.96±1.71 0.24±0.00 -53.36±8.92 94.67±0.00 
9 0.1% 5 1.25 - 1 - 223.66±2.50 0.29±0.00 -48.86±17.84 92.27±0.42 
10 0.1% 6 1 - 1 - 233.66±2.50 0.49±0.00 -44.3±4.18 98.67±0.00 
11 0.1% 2 2 - - 1 189.76±14.62 0.29±0.00 -35.1±5.66 94.10±0.58 
12 0.1% 3 1.75 - - 1 198.83±4.07 0.26±0.00 -58.8±1.32 91.91±0.04 
13 0.1% 4 1.5 - - 1 215.8±3.37 0.22±0.00 -59.3±5.94 92.12±1.17  
14 0.1% 5 1.25 - - 1 227.13±1.22 0.28±0.00 -44.3±4.18 98.58±0.00 
15 0.1% 6 1 - - 1 318.73±3.73 0.36±0.00 -58.63±20.65 98.50±0.00 
ADA: Adapalene, PRC: Precirol, MYR: Myritol, CRE: Cremophore, PLA: Plantacare, TGO: Tegocare, PdI: Polydispersity Index, ZP: Zeta Potential 
 
 
A    B 
Fig. 4: Tranmision electron microscopic photograph imaging of, A (Blank NLC), B (Adap-NLC) 
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The results of Microscopic Electronic Transmission showed that the 
form of NLC with Precirol solid lipids has a spherical shape and has a 
size below 300 nm this shows that the NLC produced has a size 
below 500 nm and has a correlation in particle size testing and is 
well distributed. This is related to the results of the NLC 
characterization of particle size and index polydispersion (fig. 4). 
CONCLUSION 
The development of Adapalene NLC formula using Precirol Ato solid 
lipid with liquid Myritol lipid and using three types of surfactants, 
namely Plantacare, Ceremophore RH 40 and Tegocare were 
successfully produced. The parameters used to characterize the 
adapalene NLC were particle size (90-300) nm, index polydispersion 
(<0.5), zeta potential-20 mv up to-60 mv, and efficient entrapment 
(84-98) % and morphological evaluation using Transmission 
electron microscopy (TEM) showed spherical shape. 
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